Literature DB >> 772721

6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.

U Ungerstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 772721     DOI: 10.1016/0306-039x(76)90016-7

Source DB:  PubMed          Journal:  Pharmacol Ther B        ISSN: 0306-039X


× No keyword cloud information.
  25 in total

1.  Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats.

Authors:  Rakesh Kumar; Lindsay Riddle; Suzy A Griffin; Peter Grundt; Amy Hauck Newman; Robert R Luedtke
Journal:  Neuropharmacology       Date:  2009-02-05       Impact factor: 5.250

2.  Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Authors:  Rakesh Kumar; Lindsay R Riddle; Suzy A Griffin; Wenhua Chu; Suwanna Vangveravong; Janet Neisewander; Robert H Mach; Robert R Luedtke
Journal:  Neuropharmacology       Date:  2009-02-05       Impact factor: 5.250

Review 3.  Kupalov's concept of shortened conditional reflexes: psychophysiological and psychopharmacological implications.

Authors:  C E Giurgea
Journal:  Pavlov J Biol Sci       Date:  1989 Jul-Sep

4.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

5.  Intranigral dopamine toxicity and alpha-synuclein response in rats.

Authors:  Cristina Gómez-Santos; Pol Giménez-Xavier; Isidre Ferrer; Santiago Ambrosio
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

6.  Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Authors:  Torun Malmlöf; Kristin Feltmann; Åsa Konradsson-Geuken; Frank Schneider; Rudolf-Giesbert Alken; Torgny H Svensson; Björn Schilström
Journal:  J Neural Transm (Vienna)       Date:  2014-06-07       Impact factor: 3.575

7.  Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

Authors:  D Offen; P M Beart; N S Cheung; C J Pascoe; A Hochman; S Gorodin; E Melamed; R Bernard; O Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

8.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

9.  Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats.

Authors:  M Diana; M Garcia-Munoz; J Richards; C R Freed
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

10.  Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test.

Authors:  Fabio S L da Conceição; Stacie Ngo-Abdalla; Jean-Christophe Houzel; Stevens K Rehen
Journal:  J Vis Exp       Date:  2010-01-15       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.